Sauter, C. S., Barker, J. N., Lechner, L., Zheng, J., Devlin, S. M., Papadopoulos, E. B., . . . Castro-Malaspina, H. (2013). A Phase 2 Study of a Non-myeloablative Allogeneic Stem Cell Transplant with Peri-transplant Rituximab in Patients with B-cell Lymphoid Malignancies: Favorably Durable Event-free Survival in Chemosensitive Patients. Biol Blood Marrow Transplant.
Dyfyniad Arddull ChicagoSauter, Craig S., et al. "A Phase 2 Study of a Non-myeloablative Allogeneic Stem Cell Transplant With Peri-transplant Rituximab in Patients With B-cell Lymphoid Malignancies: Favorably Durable Event-free Survival in Chemosensitive Patients." Biol Blood Marrow Transplant 2013.
Dyfyniad MLASauter, Craig S., et al. "A Phase 2 Study of a Non-myeloablative Allogeneic Stem Cell Transplant With Peri-transplant Rituximab in Patients With B-cell Lymphoid Malignancies: Favorably Durable Event-free Survival in Chemosensitive Patients." Biol Blood Marrow Transplant 2013.